期刊文献+

卡维地洛对急性心肌梗死患者血清Ⅲ型前胶原氨基端肽及左心功能的影响 被引量:1

Effects of Carvedilol on Serum Concentration of PⅢNP and Left Ventricular Function in Acute Myocardi al Infarction
下载PDF
导出
摘要 目的 :观察卡维地洛对急性心肌梗死患者血清Ⅲ型前胶原氨基端肽 (PⅢNP)水平及左心功能的影响。  方法 :将 80例急性心肌梗死患者随机分为常规治疗组 (40例 )和卡维地洛组 (40例 ) ,采用放射性免疫法测定血清PⅢNP及血浆内皮素的含量 ,采用彩色Doppler超声心动图仪测量左心室舒张功能和收缩功能参数。另选 3 0例体检健康者为对照组。  结果 :血清PⅢNP水平 :治疗后 1、 3、 4、 8周末常规治疗组和卡维地洛组与同组发病第 2天比较均升高 ,有显著性差异 (P <0 0 5或P <0 0 1) ;常规治疗组和卡维地洛组组间比较治疗后 1、 3、 8周亦有显著性差异 (P <0 0 5)。血浆内皮素水平、左心室射血分数和二尖瓣血流舒张早期流速 /心房收缩流速 :发病第 2天常规治疗组和卡维地洛组较对照组降低 ,有显著性差异 (P <0 0 1) ;常规治疗组和卡维地洛组组间比较治疗后 4周末亦有明显差异 (P <0 0 5或P<0 0 1)。治疗期间心脏事件发生率卡维地洛组明显低于常规治疗组 (P <0 0 5)。  结论 :卡维地洛能降低血清PⅢNP水平 。 Objective:To observe the effect of car vedilol on the elevels of serum aminoter mina l propeptide of type Ⅲ procollage (P ⅢNP) and left ventricular function in patients with ac ute myocar dial infarction(AMI). Method:A total of 80 patients with AMI w ere recruited in the study.Forty patien ts were randomized to conventional treat ment group,and the other 40 to carvedilo l treatment group.The serum PⅢNP and pla sma endothelin(ET) were measure d by specific radioimmunoassay. Color Do ppler echocardiography was performed to determine left ventricular diastolic fun ction(VE/VA) and left ventricul ar ejection fraction(LVEF). Results:After AMI,serum PⅢNP and ET we re significantly increased while VE/VA a nd LVEF obviously decreased.In compariso n with conventional treatment group,the increased serum PⅢNP and ET were signifi cantly reduced,while the decreased VE/VA and LVEF were elevated. Conlusion:Carvedilol can decrease the serum PⅢNP and improve left ventricular function.
作者 杨华 王雪涛
出处 《中国循环杂志》 CSCD 北大核心 2003年第5期333-336,共4页 Chinese Circulation Journal
关键词 卡维地洛 急性心肌梗死 血清 Ⅲ型前胶原氨基端肽 左心功能 内皮素 Myocardial infarct i on Carvedilol Aminoterminal peptide o f type Ⅲ procollagen
  • 相关文献

参考文献11

  • 1[1]Aversa P, Olivetti G, Capasso JM, et al, Cellular basis of centricular remodeling after myocardial infarction. Am J Cardiol, 1991, 68: 7-16D.
  • 2[2]Whitter P, Bonghner DR, Kloner RA. Role of collagen in acute infarction myopcardial expansion. Circulation, 1991, 74: 2123-2324.
  • 3[3]Laviades C, Mayor G, Diez J. Treatment with lisinopril normalizes serum concentrations of procollagen type P Ⅲ aminotermina peptds in patients with essential hypertension. AM J Hypertens, 1994, 7: 52-58.
  • 4薛书峰.血清前胶原末端肽在心肌纤维化评估中的应用[J].心血管病学进展,1997,18(6):368-371. 被引量:5
  • 5[5]Klappacher G, Franzen P, Haab D. Measureing extracellar matrix umover in the serum of patients with idiopathic or ischemic dilated ardiomyopathy and impact ondiagnosis. Am J Cardial, 1995, 75: 911-915.
  • 6[6]Dize J, Panizo A, Marin GJ, et al. Serum markers of collagen tyⅠ metabolism in spontaneously hypertensive rate, relation to myocardial fibrosis. Circulation, 1996, 93: 1026-1027.
  • 7[7]Jensen LT, Horslev-Petersen K, Toft P, et al. Serum aminoterminal type Ⅲ procollagen peptide reflects repair after acute myocardial infarction. Circulation, 1990, 81: 52-57.
  • 8[8]Host NB, Jensen LT, Bendixen PM, et al. The amino terminal type PⅢ procollagen provides new information on prognosis after acute myocardial infarction. Am J Cardiol, 1995, 76: 869-873.
  • 9[9]Gruseppe M, Guido G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension, 1999, 34: 724-728.
  • 10[10]Sung CP, Arleth AJ, Ohistein EH. Carvedilol inhibits vascular smooth muscle cell proliferation.J Cardiovasc Pharmacol,1993,2:221-227

二级参考文献10

共引文献59

同被引文献11

  • 1Filler G,Bokenkamp A,Hofmann W,et al.Cystatin C as a marker of GFR history,Indications and future research[J].Clin Biochem,2005,38(1):1-8.
  • 2Sarnak MJ,Katz R,Stehman-Breon CO,et al.Cystatin C concentration as a risk factor for heart failure in older adults.Ann Intern Med,2005,142(7):497-505.
  • 3陈灏珠译.心脏病学[M].第5版.北京:人民卫生出版社,2003.407-411.
  • 4Barka T,van der Noon H.Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart:use of digoxi-genin-labeled probes generated by polymerase chain reaction directly for in situ and northem blot hybridizations.J Histochem Cytochem,1993,41:1863-1867.
  • 5Bostom AG,Bausserman L,Jacques PF,et al.Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.Arterioscler Thromb Vasc Biol,1999,19:2241-2244.
  • 6Sc hiffrin EL,Lipman ML,Mann JF.Chronic kidney disease:effects on the cardiovascular system.Circulation,2007,116:85-97.
  • 7Lassus J,Harjola VP,Sund R,et al.Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.Eur Heart J,2007,28(15):1841-1847.
  • 8Ix JH,Shlipak MG,Chertow GM,et al.Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease:data from the Heart and Soul Study.Circulation,2007,115:173-179.
  • 9顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量:1279
  • 10张磊,刘希会,胡昭.以血清胱抑素C评价早期肾功能损害的临床研究[J].中国中西医结合肾病杂志,2004,5(2):88-91. 被引量:78

引证文献1

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部